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Abstract 
BACKGROUND: Typhoid fever is a disease caused by Salmonella typhi bacteria, especially attacking the 
digestive tract. Chloramphenicol is the main drug of choice for the treatment of typhoid fever. But along with the 
advancement of the medical field, other medicines were developed. Ceftriaxone is an effective drug for the 
treatment of typhoid fever in the short term. But the price of ceftriaxone is more expensive. 
AIM: The aim of this study was comparative effectiveness study of Chloramphenicol and Ceftriaxone in the 
treatment of typhoid fever in children admitted to Putri Hijau Kesdam I/BB Hospital Medan 
METHODS: This study was conducted cross-sectionally about the treatment of typhoid fever in children who were 
hospitalized at TK II PutriHijau Hospital Kesdam I/BB Medan. the patient used cloramfenikol antibiotics in 13 
patients and used ceftriaxone in 17 patients. Patient age ranges from 0-19 years. Antibiotic analysis is the best 
effectiveness using the ACER method.  
RESULTS: He results of the patient characteristics show that the children of patients who suffer from typhoid 
fever, the highest age is 12-16 years (50%), by gender male 60% and female 40%. Patients hospitalized using 
chloramfenicol averaged 6.53 days (7 days) while ceftriaxon averaged 4.17 days. The average number of direct 
medical costs in pediatric patients suffering from typhoid fever using cloramfenikol was 3,212,776/patient while 
ceftriaxon 1,967,045/patient. Cost effectiveness analysis using ACER method obtained results for 
cloramenicenicol at 492.002/day and ceftriaxon 471,713/day  
CONCLUSION: Ceftriaxone has a better treatment effectiveness compared to chloramphenicol in typhoid fever 
patients in children. 
 
 
 
 
Introduction 
 
Typhoid fever is an infectious disease caused 
by the bacterium Salmonella typhi. This disease is 
transmitted through the consumption of food or 
beverages contaminated by feces or urine of the 
infected person [1]. The characteristics of typhoid 
fever that continues to increase every day with a fever 
temperature of 38-40°C accompanied by headaches, 
nausea, and loss of appetite [2]. 
In the world, there are an estimated 16 million 
cases of typhoid fever every year, and cause 600,000 
deaths, especially in developing countries. In 
developing countries typhoid fever is a public health 
problem, where typhoid fever is widely transmitted 
through water and sanitation [1]. For 
decades, chloramphenicol has become a drug of 
choice in the treatment of typhoid fever 
where chloramphenicol is very effective against 
Salmonella typhi, but with the discovery of multi drug 
resistance (MDR) Salmonella typhi in treatment 
using chloramphenicol [3]. In the research that was 
conducted by Wasfy et al., where 
many cephalosporin generation drugs were 
examined. Ceftriaxone is considered an effective drug 
in the treatment of typhoid fever. 
Ceftriaxone is considered an effective drug in 
the treatment of short-term typhoid fever. The 
beneficial properties of this drug are that it can 
selectively damage the structure of germs and not 
interfere with the cells of the human body, has a broad 
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spectrum, quite good tissue penetration, bacterial 
resistance is still limited. But the price of Ceftriaxone 
drugs is more expensive [4]. 
Pharmacoeconomics is a description and 
analysis of the cost of therapy for a drug in the public 
health care system. Pharmacoeconomics goal is to 
influence policy makers and in decision making in a 
treatment intervention [5]. Information from the cost 
effectiveness analysis method (CEA) is needed to find 
out how much the cost of treatment for typhoid fever 
using the drug chloramphenicol and ceftriaxone. 
Cost effectiveness analysis (CEA) is an 
economic evaluation method that can be used for 
decision making in choosing the best alternative from 
several alternatives. Cost effectiveness analysis is 
usually used to assess several alternatives whose 
goals or outcomes are the same. Effectiveness is 
measured in external units such as the number of 
patients recovering, the number of actions, and 
deaths that can be prevented [6]. 
Information from the cost effectiveness 
analysis method (CEA) is needed to find out how 
much the cost of treatment for typhoid fever using the 
drug chloramphenicol and ceftriaxone. 
 
 
Material and Methods 
 
The research methodology used in this study 
is a cross-sectional method. The scope of this study 
was typhoid fever patients of children using 
chloramphenicol and ceftriaxone who were 
hospitalized in Putri Hijau KESDAM I/BB Medan for 
the period January-December 2017. The number of 
samples included in the inclusion criteria was 30 
patients. The calculation of costs was viewed from the 
direct medical costs incurred during hospitalization. 
Data was obtained from the medical records 
of patients with typhoid fever of children from January 
to December 2017. Patients with typhoid fever who 
are given antibiotic treatment with chloramphenicol or 
ceftriaxone. Information on the value of the cost of 
medical services directly obtained in hospital Putri 
Hijau KESDAM I/BB Medan. Information on drug 
costs is taken from the List of Drug Prices at the Putri 
Hijau Pharmacy Installation in KESDAM I/BB Medan. 
The data were analyzed using SPSS 20.0 the 
presence or absence of differences in treatment 
effectiveness and cost effectiveness in the treatment 
of typhoid fever between chloramphenicol and 
ceftriaxone. Medical costs are directly calculated 
using the ACER method (Average Cost Effectiveness 
Ratio). 
 
 
Results  
 
Characteristics of Patients at Putri Hijau 
Hospital KESDAM I/BB Medan Period January-
December 2017 are shown in Table 1. 
Table 1: Characteristics of Patients at Putri Hijau Hospital 
KESDAM I/BB Medan Period January-December 2017 
Information Total (N = 30) Percentage (%) 
Age 
0-5 years (toddler) 
5-11 years (childhood) 
12-16 years (early adolescence) 
17-25 years (late adolescence) 
 
1 
7 
15 
7 
 
3.3% 
23.3% 
50.0% 
23.3% 
Gender 
Male 
Female 
 
18 
12 
 
60.0% 
40.0% 
Length of stay 
3-4 days 
5-6 days 
> 7 days 
 
11 
13 
6 
 
36.7% 
43.3% 
20% 
 
 Table 2 shoe the treatment characteristics of 
patients children typhoid fever at Putri Hijau Hospital 
KESDAM I/BB Medan in the period January-
December 2017. 
Table 2: Treatment Characteristics of Patients Children 
Typhoid Fever at Putri Hijau Hospital KESDAM I/BB Medan 
Period January-December 2017  
Therapy Drugs Total (N = 30) Percentace (%) 
Antibiotic 
Chloramphenicol 
Ceftriaxone 
13 
17 
43.3% 
56.7% 
Electrolyte solution Infus Ringer Laktat 30 100.0% 
Gastrointestinal tract 
Ranitidine 
Omeprazole 
Antasida Doen 
10 
16 
1 
27.8% 
44.4% 
2.8% 
Antihistamines 
Cetrizine 
Tremenza 
1 
1 
3.3% 
3.3% 
Cough medicine 
Ambroxol syrup 
OBH syrup 
Lasal Expectorant syr 
2 
1 
1 
6.7% 
3.3% 
3.3% 
Diarrhea Medication Neo Diafrom 3 10.0% 
Antipyretic 
Paracetamol Tablet 
Paracetamol Syrup 
18 
6 
60.0% 
20.0% 
Analgetic Inj. Novalgin 7 23.3% 
Multivitamin Neurodex Tablet 6 20.0% 
Anti Emetica 
Domperidon Tablet 
Inj.Ondancentron 
5 
6 
16.7% 
20.0% 
 
 
 Comparison of the duration of treatment in 
patients with typhoid fever for children using 
Chloramphenicol and Ceftriaxone at Putri Hijau 
Hospital KESDAM I/BB Medan for the period January-
December 2017 is shown in Table 3. 
Table 3: Comparison of the duration of treatment in patients 
with typhoid fever for children using Chloramphenicol and 
Ceftriaxone at Putri Hijau Hospital KESDAM I/BB Medan for the 
period January-December 2017 
Chloramphenicol Ceftriaxone 
Gender length of stay 
(Day) 
Gender length of stay 
(Day) 
  
Male 7 Male 4 
Male 7 Female 5 
Female 6 Female 3 
Male 8 Male 3 
Male 6 Male 5 
Male 7 Male 5 
Female 7 Female 4 
Male 6 Male 4 
Male 6 Female 4 
Female 6 Female 5 
Male 7 Male 5 
Male 6 Male 3 
Male 6 Female 4 
  
Male 4 
  
Female 5 
  
Female 4 
  
Male 4 
Total 85 Total 71 
Rate 6.53 Rate 4.17 
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 Comparison of body temperature reduction in 
Typhoid Fever Patients of Children Using 
Chloramphenicol and Ceftriaxone at Putri Hijau 
Hospital KESDAM I/BB Medan for Period January-
December 2017 is shown in Table 4. 
Table 4: Comparison of body temperature reduction in Typhoid 
Fever Patients of Children Using Chloramphenicol and 
Ceftriaxone at Putri Hijau Hospital KESDAM I/BB Medan for 
Period January-December 2017 
Chloramphenicol Ceftriaxone 
Gender Body Temperature redution Gender Body Temperature redution 
 (Day)  (Day) 
Male 3 Male 2 
Male 3 Female 3 
Female 3 Female 2 
Male 4 Male 2 
Male 3 Male 3 
Male 3 Male 3 
Female 4 Female 2 
Male 3 Male 2 
Male 4 Female 2 
Female 4 Female 3 
Male 4 Male 3 
Male 4 Male 2 
Male 4 Female 2 
  Male 2 
  Female 2 
  Female 2 
  Male 2 
Total 46 Total 39 
Rate 3.5 Rate 2.3 
 
 
 
 We can see the comparison of the 
accompanying symptoms in patients with typhoid 
fever for children using Chloramphenicol and 
Ceftriaxone at Putri Hijau Hospital in KESDAM I/BB 
Medan for the period January-December 2017 in 
Table 5. 
Table 5: Comparison of the accompanying symptoms in 
patients with typhoid fever for children using Chloramphenicol 
and Ceftriaxone at Putri Hijau Hospital in KESDAM I/BB Medan 
for the period January-December 2017 
Chloramphenicol Ceftriaxone 
Gender  Symptoms are reduced 
(Days to) 
Gender Symptoms are reduced 
(Days to) 
Male  7 Male 4 
Male 7 Female 5 
Female  6 Female 3 
Male 8 Male 3 
Male 6 Male 5 
Female  7 Male 5 
Female  7 Female 4 
Male 6 Male 4 
Male 6 Female 4 
Female  6 Female 5 
Male 7 Male 5 
Male 6 Male 3 
Male 6 Female 4 
  Male 4 
  Female 5 
  Female 4 
  Male 4 
Total 85 Total 71 
Rate 6.53 Rate 4.17 
 
 
 Comparison of Inpatient Costs for Patients 
with Typhoid Fever Children Using Chloramphenicol 
and Ceftriaxone at Putri Hijau Hospital KESDAM 
I/Medan BB Period January-December 2017 is shown 
in Table 6. 
 
 
 
 
 
 
Table 6: Comparison of Inpatient Costs for Patients with 
Typhoid Fever Children Using Chloramphenicol and 
Ceftriaxone at Putri Hijau Hospital KESDAM I/Medan BB Period 
January-December 2017 
Chloramphenicol Ceftriaxone 
Gender Cost of Hospitalization (RP) Gender Cost of Hospitalization (RP) 
Male 2.800.000 Male 1.600.000 
Male 2.800.000 Female 2.000.000 
Female 2.400.000 Female 1.200.000 
Male 3.200.000 Male 1.200.000 
Male 2.400.000 Male 2.000.000 
Male 2.800.000 Male 2.000.000 
Female 2.800.000 Female 1.600.000 
Male 2.400.000 Male 1.600.000 
Male 2.400.000 Female 1.600.000 
Female 2.400.000 Female 2.000.000 
Male 2.800.000 Male 2.000.000 
Male 2.400.000 Male 1.200.000 
Male 2.400.000 Female 1.600.000 
  Male 1.600.000 
  Female 2.000.000 
  Female 1.600.000 
  Male 1.600.000 
Total 34.000.000 Total 28.400.000 
Rate 2.615.384 Rate 1.670.588 
 
 
 Comparison of Drug Costs in Patients with 
Typhoid Fever in Children Using Chloramphenicol and 
Ceftriaxone at Putri Hijau Hospital KESDAM I/BB 
Medan for Period January-December 2017 is shown 
in Table 7. 
Table 7: Comparison of Drug Costs in Patients with Typhoid 
Fever in Children Using Chloramphenicol and Ceftriaxone at 
Putri Hijau Hospital KESDAM I/BB Medan for Period January-
December 2017 
Chloramphenicol Ceftriaxone 
Gender Drug Costs (RP) Gender Drug Costs (RP) 
Male 625,479 Male 242,532 
Male 583,559 Female 266,415 
Female 599,507 Female 164,169 
Male 428,124 Male 167,409 
Male 901,822 Male 313,185 
Male 586,800 Male 299,565 
Female 582,838 Female 211,764 
Male 852,089 Male 221,664 
Male 494,802 Female 278,268 
Female 499,140 Female 387,754 
Male 629,133 Male 461,250 
Male 444,618 Male 270,201 
Male 538,182 Female 298,024 
  Male 279,036 
  Female 463,704 
  Female 372,811 
  Male 341,988 
Total 7,766,093 Total 5,039,775 
Rate 597,391 Rate 296,457 
 
 We can see the average cost of inpatient and 
drug costs in patients with typhoid fever in children 
using chloramphenicol and ceftriaxone in Putri Hijau 
Hospital KESDAM I/BB Medan for the period January-
December 2017 in Table 8. 
Table 8: Average Cost of Inpatient and Drug Costs in Patients 
with Typhoid Fever in Children Using Chloramphenicol and 
Ceftriaxone in Putri Hijau Hospital KESDAM I/BB Medan for 
Period January-December 2017 
Chloramphenicol Ceftriaxone 
The average cost of hospitalization + drug 
costs in patients 
The average cost of hospitalization + drug 
costs in patients 
Rp.3,212,776/patient Rp.1,967,045/patient 
 
 ACER Calculation Results for Patients with 
Typhoid Fever Children Using Chloramphenicol and 
Ceftriaxone in the Putri Hijau Hospital KESDAM 
I/Medan BB Period January-December 2017 is shown 
in Table 9. 
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Table 9: ACER Calculation Results for Patients with Typhoid 
Fever Children Using Chloramphenicol and Ceftriaxone in the 
Putri Hijau Hospital KESDAM I/Medan BB Period January-
December 2017 
Cost Item Chloramphenicol Ceftriaxone 
Rate costs Rp 3,212,776 Rp 1,967,045 
The average patient is hospitalized 6.53 day 4.17 day 
ACER (B/E) Rp.492,002.50/day Rp.471,713.56/day 
 
 
 
Discussion 
 
Typhoid fever is a disease that is closely 
related to environmental sanitation. Based on data 
obtained from 30 pediatric patients diagnosed with 
typhoid fever can be seen that many children at the 
age of 12-16 years suffer from typhoid fever 50% 
compared to children aged 0-5 years, 5-11 years, and 
17-25 years. At the age of 12-16 years is the age of 
school children who have a lot of activity, and lack of 
attention to cleanliness. Children at school age are at 
the highest risk of developing Salmonella infection 
because the immune system is not perfect so bacteria 
enter the body and develop [7]. The gender of male 
typhoid fever of children as much as 60% of people 
and in female as much as 40%. Men suffering typhoid 
fever more than women because it is associated with 
male activities that are often outside the home so that 
the men to be infected with Salmonella more often 
than women [7]. 
Typhoid fever in children often causes 
patients to be treated in hospitals. The long treated in 
typhoid fever is the highest 5-6 days (43.3%). Patients 
admitted to hospital because fever typhoid range 7-14 
days to reach level of healing. 
In this study patients using ceftriaxone more 
from chloramphenicol. Ceftriaxone is considered an 
effective antibiotic for the treatment of typhoid fever 
short term. Ceftriaxone selectively can damage the 
structure of the germ that can kill Salmonella typhi, 
has a board spectrum, not to interfere with human 
body cells, germ resistance is limited and there are no 
harmful side effects when given to children [8], [9]. 
 Typhoid fever often occurs on an ineffecient 
provision of electrolytes so that the grant should be 
also given intravenous fluids. In typhoid fever patients 
must get enough fluids, both orally and parenterally. 
Parenteral fluid is indicated in patients with severe 
pain and a decrease in consciousness and difficulty 
eating. Administering intravenous fluids in accordance 
with the guideline for the management of typoid fever 
[10]. 
Typhoid fever disease is often accompanied 
by other symptoms such as abdominal pain, 
headaches, nausea, vomiting, diarrhea, muscle pain. 
Symptom the most common follow up is a disorder on 
digestion so the use of omeprazole drug most often 
given [11]. Granting of proton pump inhibitor in this 
case omeprazole fairly safe provided in children to 
overcome the symptoms of digestive disorders that 
often follow the typhoid fever [12]. 
The success of the treatment can be seen 
from the length of patient stay hospitalized, 
temperature changes, disappearance of fever and 
reduced symptoms that follow due to the typhoid fever 
[11]. In this study the effectiveness of treatment was 
assessed based on the comparison of length of 
treatment, disappearance of fever and reduced 
symptoms that follow due to the typhoid fever 
between typhoid fever in children patients using 
Chloramphenicol and those taking Ceftriaxone. The 
average length of stay in typhoid fever in children 
using Chloramphenicol is 6.53 days and the average 
length of stay in typhoid fever patients using 
Ceftriaxone is 4.17 days. This shows that patients 
taking ceftriaxone have a faster treatment time than 
patients who use chloramphenicol. This is accordance 
with the research done Lili in Fatmawati Hospital 
Jakarta where typoid fever children patients given 
ceftriaxone average admitted 4.408 days [11]. 
Calculated the average disappearance in 
children patients using chloramphenicol with patients 
taking ceftriaxone. Then the data obtained for body 
temperature drop using chloramphenicol on average 
3.5 days and on average using ceftriaxone at 2.3 
days. This shows that typhoid fever patients who use 
ceftriaxone have fever faster than chloramphenicol. 
These data coresspond to the research done at 
Fatmawati hospital explained that the disappearance 
of fever in patients using ceftriaxone thypoid fever 
children with an average 3.449 days [11]. Research 
conducted by Susatyo stating the same thing that the 
treatment of children typhoid fever using Ceftriaxone 
3.3 days while Chloramphenicol 5.8 days [13]. 
Chloramphenicol is an effective drug in the treatment 
of typhoid fever. But Choramphenicol is not effective 
in killing germs. Therefore, ceftriaxone is an effective 
drug in the treatment of typhoid fever in the short term 
[14]. 
Direct medical costs can be seen based on 
the comparison of the total cost of hospitalization 
between typhoid fever patients using chloramphenicol 
and ceftriaxone. The average cost of hospitalization 
for patients using cholaramphenicol is 
Rp.2,615,384/patient and the average cost of 
hospitalization in patients using ceftriaxone is 
Rp.1,670,588/patient. Drug costs in patients using 
chloramphenicol are more expensive than patients 
who use ceftriaxone. This happens because patients 
who use chloramphenicol are treated longer than 
patients who use ceftriaxone. So that typhoid fever 
patients who use chloramphenicol have to pay more 
than patients who use ceftriaxone. Rani 2018 do 
research on cost effectiveness analysis of ceftriaxone 
and non-ceftriaxone on typhoid fever patients get the 
same result that patients using ceftriaxone average 
hospitalization cost lower compared non ceftriaxone 
[15]. The average cost of drugs in patients using 
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cholaramphenicol is Rp.597,391.76/patient and the 
average cost of the drug in patients using ceftriaxone 
is Rp.296,457.35/patient. This shows that the cost of 
drugs in patients using chloramphenicol is more 
expensive than patients who use ceftriaxone. This 
happens because patients who use chloramphenicol 
are treated longer than patients who use ceftriaxone. 
So that typhoid fever patients who use 
chloramphenicol have to pay more than patients who 
use ceftriaxone. 
The average cost of hospitalization + drug 
costs in patients using cholaramphenicol is equal to 
Rp 3,212,776/patient and the average cost of 
hospitalization + drug costs in patients using 
ceftriaxone is Rp 1,967,045/patient. 
In the assessment of cost effectiveness 
analysis can use analysis with the ACER method. 
ACER is a cost needed to increase the effectiveness 
of each treatment [16]. The treatment chosen is the 
lowest effective cost. ACER value from 
chloramphenicol therapy is Rp.492,002/day while 
ceftriaxone therapy is Rp.471,713/day. 
In patients using chloramphenicol, patients must 
spend Rp.492,002/day and in patients using 
ceftriaxone, patients have to pay Rp.471,713/day to 
get treatment effectiveness. 
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